Literature DB >> 21441449

CXCR3 deficiency exacerbates liver disease and abrogates tolerance in a mouse model of immune-mediated hepatitis.

Annette Erhardt1, Claudia Wegscheid, Benjamin Claass, Antonella Carambia, Johannes Herkel, Hans-Willi Mittrücker, Ulf Panzer, Gisa Tiegs.   

Abstract

The chemokine receptor CXCR3 is preferentially expressed by Th1 cells and critically involved in their recruitment to inflamed tissue. In a mouse model of immune-mediated liver injury inducible by Con A, we investigated the role of CXCR3 in acute IFN-γ-mediated hepatitis as well as in tolerance induction, which has been shown to depend on IL-10-producing CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs). Induction of Con A hepatitis resulted in increased intrahepatic expression of the CXCR3 ligands CXCL9, CXCL10, and CXCL11. CXCR3(-/-) mice developed a more severe liver injury with higher plasma transaminase activities and a more pronounced Th1/Th17 response compared with wild-type (wt) animals upon Con A injection. Moreover, CXCR3(-/-) mice did not establish tolerance upon Con A restimulation, although Tregs from CXCR3(-/-) mice were still suppressive in an in vitro suppression assay. Instead, Tregs failed to accumulate in livers of CXCR3(-/-) mice upon Con A restimulation in contrast to those from wt animals. Con A-tolerant wt mice harbored significantly increased numbers of intrahepatic CXCR3(+)T-bet(+) Tregs that produced IL-10 compared with nontolerant animals. IFN-γ deficiency or anti-IFN-γ Ab treatment demonstrated that conversion to CXCR3(+)T-bet(+) Tregs depended on a Th1 response. Accordingly, in an immunotherapeutic approach, CD4(+)CD25(+)Foxp3(+) Tregs from Con A-pretreated CXCR3-deficient mice failed to protect against Con A-induced hepatitis, whereas Tregs from Con A-tolerant wt mice allowed CXCR3-deficient mice to recover from Con A hepatitis. In summary, CXCR3(+)T-bet(+)IL-10(+) Tregs are generated in the liver in dependence of IFN-γ, then disseminated into the organism and specifically migrate into the liver, where they limit immune-mediated liver damage.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21441449     DOI: 10.4049/jimmunol.1003750

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  38 in total

1.  Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells.

Authors:  Thomas Duhen; Rebekka Duhen; Antonio Lanzavecchia; Federica Sallusto; Daniel J Campbell
Journal:  Blood       Date:  2012-03-21       Impact factor: 22.113

2.  Protective effect of FTY720 on several markers of liver injury induced by concanavalin a in mice.

Authors:  Xiao-Dong Yin; Pei-Jie Jia; Yan Pang; Jing-Hua He
Journal:  Curr Ther Res Clin Exp       Date:  2012-09

3.  JUNB/AP-1 controls IFN-γ during inflammatory liver disease.

Authors:  Martin K Thomsen; Latifa Bakiri; Sebastian C Hasenfuss; Rainer Hamacher; Lola Martinez; Erwin F Wagner
Journal:  J Clin Invest       Date:  2013-11-08       Impact factor: 14.808

4.  Hepatic serum amyloid A1 aggravates T cell-mediated hepatitis by inducing chemokines via Toll-like receptor 2 in mice.

Authors:  Young Rae Ji; Hei Jung Kim; Ki Beom Bae; Sanggyu Lee; Myoung Ok Kim; Zae Young Ryoo
Journal:  J Biol Chem       Date:  2015-04-06       Impact factor: 5.157

5.  Vascular endothelial growth factor promotes fibrosis resolution and repair in mice.

Authors:  Liu Yang; Junghee Kwon; Yury Popov; Gabriella B Gajdos; Tamas Ordog; Rolf A Brekken; Debabrata Mukhopadhyay; Detlef Schuppan; Yan Bi; Douglas Simonetto; Vijay H Shah
Journal:  Gastroenterology       Date:  2014-02-04       Impact factor: 22.682

6.  STAP-2 Protein Expression in B16F10 Melanoma Cells Positively Regulates Protein Levels of Tyrosinase, Which Determines Organs to Infiltrate in the Body.

Authors:  Yuichi Sekine; Sumihito Togi; Ryuta Muromoto; Shigeyuki Kon; Yuichi Kitai; Akihiko Yoshimura; Kenji Oritani; Tadashi Matsuda
Journal:  J Biol Chem       Date:  2015-05-28       Impact factor: 5.157

7.  BRG1-mediated immune tolerance: facilitation of Treg activation and partial independence of chromatin remodelling.

Authors:  Barbara H Chaiyachati; Anant Jani; Yisong Wan; Haichang Huang; Richard Flavell; Tian Chi
Journal:  EMBO J       Date:  2013-01-15       Impact factor: 11.598

8.  CXCR3 axis in patients with primary biliary cirrhosis: a possible novel mechanism of the effect of ursodeoxycholic acid.

Authors:  P Manousou; G Kolios; I Drygiannakis; M Koulentaki; K Pyrovolaki; A Voumvouraki; G Notas; L Bourikas; H A Papadaki; E Kouroumalis
Journal:  Clin Exp Immunol       Date:  2013-04       Impact factor: 4.330

9.  Hepatic overexpression of cAMP-responsive element modulator α induces a regulatory T-cell response in a murine model of chronic liver disease.

Authors:  Nadine Kuttkat; Antje Mohs; Kim Ohl; Guido Hooiveld; Thomas Longerich; Klaus Tenbrock; Francisco Javier Cubero; Christian Trautwein
Journal:  Gut       Date:  2016-09-29       Impact factor: 23.059

10.  T-Bet Enhances Regulatory T Cell Fitness and Directs Control of Th1 Responses in Crescentic GN.

Authors:  Anna Nosko; Malte A Kluger; Paul Diefenhardt; Simon Melderis; Claudia Wegscheid; Gisa Tiegs; Rolf A K Stahl; Ulf Panzer; Oliver M Steinmetz
Journal:  J Am Soc Nephrol       Date:  2016-06-13       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.